Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2005, Vol. 105, No. 4, pp. 1632-1639.
Prepublished online as a Blood First Edition Paper on October 21, 2004; DOI 10.1182/blood-2004-08-3196.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-08-3196v1
105/4/1632    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pages, F.
Right arrow Articles by Henglein, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pages, F.
Right arrow Articles by Henglein, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 19, 2004
Accepted October 13, 2004

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B-cells

Franck Pages, Jerome Galon, Galina Karaschuk, Diana Dudziak, Mathieu Camus, Vladimir Lazar, Sophie Camilleri-Broet, Christine Lagorce-Pages, Sophie Lebel-Binay, Gerhard Laux, Wolf-Herman Fridman, and Berthold Henglein*

INSERM U 255, Centre de Recherches Biomedicales des Cordeliers, Paris, France; Service d'Immunologie Biologique, Hopital Europeen Georges Pompidou, Paris, France
INSERM U 255, Centre de Recherches Biomedicales des Cordeliers, Paris, France
Institut fur Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum fur Umwelt und Gesundheit, Munchen, Germany
Unite de Genomique Fonctionnelle, Institut Gustave Roussy, Villejuif, France
INSERM U 255, Centre de Recherches Biomedicales des Cordeliers, Paris, France; Service d'Anatomie Pathologique, Hopital Hotel-Dieu, AP-HP, Paris, France
Service d'Anatomie Pathologique, Hopital Avicenne, AP-HP, Bobigny, France
INSERM U 255, Centre de Recherches Biomedicales des Cordeliers, Paris, France; CNRS UMR 7098, Universite Pierre et Marie Curie, Paris, France

* Corresponding author; email: Berthold.Henglein{at}snv.jussieu.fr.

Epstein-Barr virus (EBV) latently infects and immortalizes B-lymphocytes and causes lymphoproliferative malignancies. We show here that the EBV nuclear antigen EBNA2 induces expression of the two chains of the interleukin-18 receptor (IL-18R) in Burkitt lymphoma (BL) cell lines and in non-transformed B-cells. Activation of IL-18R expression by EBNA2 is independent of its interaction with the transcriptional repressor, RBPJ{kappa}. It occurs in the absence of any other viral protein but requires de novo synthesis of cellular proteins. IL-18R induction is a highly specific function of EBNA2, since neither other EBV latent proteins, nor the cellular proteins c-myc or Notch can exert this effect. Using cDNA microarray expression profiling, we find that the IL-18 receptor expressed in EBV-infected BL cells has signaling capacity, since IL-18 significantly modified gene expression. We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-lymphomas from AIDS patients.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
A. Orozco, E. Gemmell, M. Bickel, and G.J. Seymour
Interleukin 18 and Periodontal Disease
J. Dent. Res., July 1, 2007; 86(7): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, M. Tosolini, M. Camus, A. Berger, P. Wind, et al.
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Science, September 29, 2006; 313(5795): 1960 - 1964.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Mohan, J. Dement-Brown, S. Maier, T. Ise, B. Kempkes, and M. Tolnay
Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1
Blood, June 1, 2006; 107(11): 4433 - 4439.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Zhao, S. Maruo, A. Cooper, M. R. Chase, E. Johannsen, E. Kieff, and E. Cahir-McFarland
RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines
PNAS, February 7, 2006; 103(6): 1900 - 1905.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020